Ashkan Lashkari is an expert in the field of Oncology. She studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. Ashkan Lashkari has written publications. She has 6 publications published with PubMed. The lastest publication is: 'Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.' Ashkan Lashkari, MD accepts Medicare payments and is listed with Medicare.gov.
NPI NUMBER | 1528284627 | |
NPPES Provider LastName | LASHKARI | |
NPPES Provider FirstName | ASHKAN | |
NPPES Provider ZIPCode | 913071474 | |
NPPES Provider State | CA | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 1166.0 | |
Distinct Opioid Count | 3.0 | |
Opioid Claim Count | 57.0 | |
Percent Opioid Claims | 4.89 |
National Provider Identifier [NPI] | 1528284627 |
Last Name Of The Provider | LASHKARI |
First Name Of The Provider | ASHKAN |
View All |